Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
8/9/2024 | Outperform → Mkt Perform | Raymond James | |
5/10/2024 | $16.00 → $17.00 | Outperform | Hovde Group |
1/8/2024 | $15.50 | Buy → Neutral | B. Riley Securities |
7/28/2023 | $15.25 | Buy | B. Riley Securities |
4 - Blue Owl Capital Corp (0001655888) (Issuer)
4 - Blue Owl Capital Corp (0001655888) (Issuer)
4 - Blue Owl Capital Corp (0001655888) (Issuer)
8-K - Blue Owl Capital Corp (0001655888) (Filer)
8-K - Blue Owl Capital Corp (0001655888) (Filer)
497AD - Blue Owl Capital Corp (0001655888) (Filer)
Raymond James downgraded Blue Owl Capital from Outperform to Mkt Perform
Hovde Group reiterated coverage of Blue Owl Capital with a rating of Outperform and set a new price target of $17.00 from $16.00 previously
B. Riley Securities downgraded Blue Owl Capital from Buy to Neutral and set a new price target of $15.50
4 - Blue Owl Capital Corp (0001655888) (Issuer)
4 - Blue Owl Capital Corp (0001655888) (Issuer)
4 - Blue Owl Capital Corp (0001655888) (Issuer)
KBRA assigns a rating of BBB+ to Blue Owl Capital Corporation's (NYSE:OBDC, the company", )) $400 million, 5.95% senior unsecured notes due 2029. The Outlook for the rating is Stable. The company intends to use proceeds to pay down secured debt. Key Credit Considerations The rating is supported by OBDC's ties to the $128.4 billion Blue Owl Credit platform that maintains a strong reputation and leadership position in the $1.7 trillion private credit market. OBDC's experienced management team that has decades of experience working in the private markets has built a high credit quality direct lending platform to finance mainly sponsor-backed portfolio companies in the upper middle market.
Wingspire Equipment Finance, a prominent large-ticket equipment financing company, has announced a $35 million equipment financing deal with a top sponsor-backed medical technology company. This client aims to transform the filling and finishing process for sterile liquid medicines and vaccines. The financing will enable the purchase of several custom Blow-Fill-Seal (BFS) machines, significantly boosting production capacity. The medical technology company specializes in helping pharmaceutical manufacturers design rapidly scalable, cost-efficient drug delivery systems. The company recently made monumental innovations in its prefilled injection devices, reducing costs by nearly 50%. This adv
NEW YORK, Nov. 6, 2024 /PRNewswire/ -- Blue Owl Capital Corporation III (NYSE:OBDE, or the ", Company", )) today announced financial results for its third quarter ended September 30, 2024. THIRD QUARTER 2024 HIGHLIGHTS Third quarter net investment income ("NII") per share of $0.41, in-line with the prior quarter and exceeding the regular dividend of $0.35 per share by 17%As previously announced in January, the Board of Directors (the "Board") declared five special dividends of $0.06 per share; the third of which will be payable on or before December 13, 2024 to shareholders of record as of November 29, 202410.6%1 annualized dividend yield based on third quarter net asset value ("NAV") per s
Keefe, Bruyette & Woods analyst Paul Johnson downgrades Blue Owl Capital (NYSE:OBDC) from Outperform to Market Perform and announces $16 price target.
4 analysts have shared their evaluations of Blue Owl Capital (NYSE:OBDC) during the recent three months, expressing a mix of bullish and bearish perspectives. The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 3 0 0 0 Last 30D 0 1 0 0 0 1M Ago 1 0 0 0 0 2M Ago 0 1 0 0 0 3M Ago 0 1 0 0 0 Analysts have recently evaluated Blue Owl Capital and provided 12-month price targets. The average target is $16.75, accompanied by a high estimate of $18.00 and a low estimate of $16.00. Witnessing
RBC Capital analyst Kenneth Lee maintains Blue Owl Capital (NYSE:OBDC) with a Outperform and raises the price target from $16 to $17.
NEW YORK, Nov. 6, 2024 /PRNewswire/ -- Blue Owl Capital Corporation III (NYSE:OBDE, or the ", Company", )) today announced financial results for its third quarter ended September 30, 2024. THIRD QUARTER 2024 HIGHLIGHTS Third quarter net investment income ("NII") per share of $0.41, in-line with the prior quarter and exceeding the regular dividend of $0.35 per share by 17%As previously announced in January, the Board of Directors (the "Board") declared five special dividends of $0.06 per share; the third of which will be payable on or before December 13, 2024 to shareholders of record as of November 29, 202410.6%1 annualized dividend yield based on third quarter net asset value ("NAV") per s
NEW YORK, Nov. 6, 2024 /PRNewswire/ -- Blue Owl Capital Corporation (NYSE: OBDC, or the "Company") today announced financial results for its third quarter ended September 30, 2024. THIRD QUARTER 2024 HIGHLIGHTS Third quarter net investment income ("NII") per share of $0.47, exceeding the regular dividend of $0.37 per share by 27% and generating an ROE of 12.4%Based on OBDC's supplemental dividend framework, the Board of Directors (the "Board") declared a third quarter supplemental dividend of $0.05 per shareTotal dividends for the third quarter were $0.42 per share, representing an 11.0% annualized dividend yield based on third quarter net asset value ("NAV") per shareNAV per share of $15.2
NEW YORK, Oct. 2, 2024 /PRNewswire/ -- Blue Owl Capital Corporation (NYSE: OBDC) ("OBDC") today announced it will release its financial results for the third quarter ended September 30, 2024 on Wednesday, November 6, 2024 after market close. OBDC invites all interested persons to its webcast / conference call on Thursday, November 7, 2024 at 10:00 a.m. Eastern Time to discuss its third quarter ended September 30, 2024 financial results. Conference Call Information: The conference call will be broadcast live at 10:00 a.m. Eastern Time on the Events section of OBDC's website at www.blueowlcapitalcorporation.com. Please visit the website to test your connection before the webcast. Participants